Search Results 921-930 of 14753 for anti-TNF drugs

1. Darunavir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide (Oral Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Symtuza. Descriptions. Darunavir, cobicistat ...

2. Antifibrotics may extend lives for patients with IPF - Mayo Clinic News Network

   Mayo Clinic researchers recently learned that patients who are taking antifibrotic drugs for idiopathic pulmonary fibrosis (IPF) have a better chance of ...

3. Exenatide (Subcutaneous Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Bydureon; BYDUREON BCise; Byetta. Descriptions.

4. Antivenin (Crotalidae) Polyvalent Immune Fab (Intravenous Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Crofab. Descriptions. Pit viper antivenin injection is used ...

5. Lumacaftor And Ivacaftor (Oral Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Orkambi. Descriptions. Lumacaftor and ivacaftor combination ...

6. Mayo Clinic Studying Genomics of Antiplatelet Heart Medication

   Two-year study of Plavix and Brilinta to include approximately 5,300 patients from 15 hospitals worldwide; participant DNA biobank to help elucidate ...

7. Ropeginterferon Alfa-2b-Njft (Subcutaneous Route) Precautions - Mayo Clinic

   Using this medicine while you are pregnant can harm your unborn baby. Use an effective form of birth control to keep from getting pregnant during treatment with ...

8. Neomycin, Polymyxin B, And Gramicidin (Ophthalmic Route) Precautions - Mayo Clinic

   Precautions. Drug information provided by: Merative, Micromedex®. If your symptoms do not improve within a few days, or if they become worse, ...

9. Cancer Immunotherapy: IMPRESS Study - Center for Individualized Medicine - Mayo Clinic Research

   To date, the Food and Drug Administration has approved several anti-PD-1 and anti-PD-1 ligand (anti-PD-L1) treatments based on data that provides renewed ...

10. Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Stage IV Non-Small Cell Lung Cancer Patients Who Are PD-L1 Negative - Mayo Clinic

    usual treatment alone in treating patients with non-small cell lung cancer that has spread to nearby tissue or lymph nodes (advanced) or has spread to other ...